Screening intervention to identify eligible patients and improve accrual to phase II-IV oncology clinical trials.

Abstract

PURPOSE Low enrolment rates in clinical trials present a barrier to the development of novel cancer therapies. Currently, only 3% of patients with cancer participate, and many studies fail to achieve necessary enrolment. The objective of this study was to evaluate whether a screening intervention to identify potentially eligible patients (PEPs) would… (More)
DOI: 10.1200/JOP.2012.000763

Topics

2 Figures and Tables

Cite this paper

@article{Chen2013ScreeningIT, title={Screening intervention to identify eligible patients and improve accrual to phase II-IV oncology clinical trials.}, author={Leo C. Chen and Janice C Grant and Winson Y Cheung and Hagen Fritz Kennecke}, journal={Journal of oncology practice}, year={2013}, volume={9 4}, pages={e174-81} }